nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—ADORA2A—forebrain—narcolepsy	0.0133	0.107	CbGeAlD
Pentoxifylline—NT5E—midbrain—narcolepsy	0.0124	0.099	CbGeAlD
Pentoxifylline—ADORA2A—GPCRs, Other—P2RY11—narcolepsy	0.0123	0.014	CbGpPWpGaD
Pentoxifylline—PDE4B—G alpha (s) signalling events—P2RY11—narcolepsy	0.0123	0.014	CbGpPWpGaD
Pentoxifylline—PDE5A—forebrain—narcolepsy	0.0121	0.0973	CbGeAlD
Pentoxifylline—ADORA1—forebrain—narcolepsy	0.0115	0.0923	CbGeAlD
Pentoxifylline—ADORA2A—G alpha (s) signalling events—P2RY11—narcolepsy	0.00959	0.011	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—HCRTR2—narcolepsy	0.00874	0.00998	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—HCRTR1—narcolepsy	0.00874	0.00998	CbGpPWpGaD
Pentoxifylline—PDE4B—forebrain—narcolepsy	0.00851	0.0683	CbGeAlD
Pentoxifylline—ADORA2B—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00841	0.00961	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00841	0.00961	CbGpPWpGaD
Pentoxifylline—ADORA1—medulla oblongata—narcolepsy	0.00831	0.0667	CbGeAlD
Pentoxifylline—ADORA2B—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00813	0.00928	CbGpPWpGaD
Pentoxifylline—NT5E—brain—narcolepsy	0.00776	0.0622	CbGeAlD
Pentoxifylline—ADORA1—midbrain—narcolepsy	0.0076	0.0609	CbGeAlD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00721	0.00824	CbGpPWpGaD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00721	0.00824	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00715	0.00817	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00715	0.00817	CbGpPWpGaD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00696	0.00795	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00691	0.00789	CbGpPWpGaD
Pentoxifylline—ADORA2B—G alpha (s) signalling events—NPS—narcolepsy	0.00684	0.00781	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—HCRTR1—narcolepsy	0.00675	0.00771	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—HCRTR2—narcolepsy	0.00675	0.00771	CbGpPWpGaD
Pentoxifylline—ADORA2B—brain—narcolepsy	0.00665	0.0533	CbGeAlD
Pentoxifylline—PDE4A—G alpha (s) signalling events—NPS—narcolepsy	0.00621	0.00709	CbGpPWpGaD
Pentoxifylline—PDE4B—medulla oblongata—narcolepsy	0.00615	0.0493	CbGeAlD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00613	0.007	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00613	0.007	CbGpPWpGaD
Pentoxifylline—PDE4A—brain—narcolepsy	0.00592	0.0475	CbGeAlD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00592	0.00676	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00592	0.00676	CbGpPWpGaD
Pentoxifylline—PDE4B—G alpha (s) signalling events—NPS—narcolepsy	0.00574	0.00656	CbGpPWpGaD
Pentoxifylline—ADORA1—G alpha (i) signalling events—PENK—narcolepsy	0.00564	0.00645	CbGpPWpGaD
Pentoxifylline—PDE4B—midbrain—narcolepsy	0.00562	0.0451	CbGeAlD
Pentoxifylline—ADORA2A—brain—narcolepsy	0.00553	0.0443	CbGeAlD
Pentoxifylline—ADORA2A—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00552	0.00631	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00552	0.00631	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—HCRTR2—narcolepsy	0.00549	0.00627	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—HCRTR1—narcolepsy	0.00549	0.00627	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00534	0.0061	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—P2RY11—narcolepsy	0.0053	0.00606	CbGpPWpGaD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00528	0.00603	CbGpPWpGaD
Pentoxifylline—PDE5A—brain—narcolepsy	0.00504	0.0404	CbGeAlD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00503	0.00575	CbGpPWpGaD
Pentoxifylline—ADORA1—brain—narcolepsy	0.00477	0.0383	CbGeAlD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00473	0.00541	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00473	0.00541	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—HCRTR2—narcolepsy	0.00467	0.00533	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—HCRTR1—narcolepsy	0.00467	0.00533	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00459	0.00525	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00457	0.00522	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—HCRT—narcolepsy	0.00451	0.00515	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—P2RY11—narcolepsy	0.00451	0.00515	CbGpPWpGaD
Pentoxifylline—ADORA2A—G alpha (s) signalling events—NPS—narcolepsy	0.00449	0.00513	CbGpPWpGaD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00449	0.00513	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00449	0.00513	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—CHKB—narcolepsy	0.00447	0.00511	CbGpPWpGaD
Pentoxifylline—ADORA1—G alpha (i) signalling events—HRH3—narcolepsy	0.00421	0.00481	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—PENK—narcolepsy	0.00402	0.00459	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—NPS—narcolepsy	0.00395	0.00451	CbGpPWpGaD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00393	0.00449	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.0039	0.00446	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00389	0.00444	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—HCRT—narcolepsy	0.00383	0.00438	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00381	0.00436	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—HCRTR2—narcolepsy	0.0036	0.00412	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—HCRTR1—narcolepsy	0.0036	0.00412	CbGpPWpGaD
Pentoxifylline—PDE4B—brain—narcolepsy	0.00353	0.0283	CbGeAlD
Pentoxifylline—ADORA2A—GPCR ligand binding—P2RY11—narcolepsy	0.00348	0.00398	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00346	0.00396	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCRs, Other—HTR2A—narcolepsy	0.00346	0.00395	CbGpPWpGaD
Pentoxifylline—ADORA2A—Monoamine Transport—TNF—narcolepsy	0.00343	0.00392	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—TRH—narcolepsy	0.00342	0.0039	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—PENK—narcolepsy	0.00342	0.0039	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00335	0.00382	CbGpPWpGaD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00326	0.00372	CbGpPWpGaD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00326	0.00372	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—HCRTR1—narcolepsy	0.0031	0.00354	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—HCRTR2—narcolepsy	0.0031	0.00354	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—NPS—narcolepsy	0.00305	0.00348	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—CPT1B—narcolepsy	0.00304	0.00347	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00301	0.00344	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—P2RY11—narcolepsy	0.003	0.00342	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—HRH3—narcolepsy	0.003	0.00342	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—HCRT—narcolepsy	0.00296	0.00338	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00295	0.00337	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—TRH—narcolepsy	0.00291	0.00332	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—HCRTR2—narcolepsy	0.00282	0.00322	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—HCRTR1—narcolepsy	0.00282	0.00322	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—HCRTR2—narcolepsy	0.00282	0.00322	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—HCRTR1—narcolepsy	0.00282	0.00322	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00277	0.00317	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00277	0.00317	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—P2RY11—narcolepsy	0.00272	0.00311	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—P2RY11—narcolepsy	0.00272	0.00311	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—PENK—narcolepsy	0.00264	0.00301	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00264	0.00301	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00264	0.00301	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—HCRTR1—narcolepsy	0.00261	0.00298	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—HCRTR2—narcolepsy	0.00261	0.00298	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00258	0.00295	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—HCRTR2—narcolepsy	0.00256	0.00292	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—HCRTR1—narcolepsy	0.00256	0.00292	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—HCRT—narcolepsy	0.00255	0.00291	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—P2RY11—narcolepsy	0.00255	0.00291	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—HRH3—narcolepsy	0.00255	0.00291	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—P2RY11—narcolepsy	0.00252	0.00288	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—TAC1—narcolepsy	0.00248	0.00284	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—NPS—narcolepsy	0.00248	0.00284	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—P2RY11—narcolepsy	0.00247	0.00282	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—HCRTR2—narcolepsy	0.0024	0.00274	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—HCRTR1—narcolepsy	0.0024	0.00274	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—HCRTR2—narcolepsy	0.00237	0.0027	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—HCRTR1—narcolepsy	0.00237	0.0027	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—HCRT—narcolepsy	0.00231	0.00264	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—P2RY11—narcolepsy	0.00231	0.00264	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—HCRT—narcolepsy	0.00231	0.00264	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00229	0.00262	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—P2RY11—narcolepsy	0.00229	0.00261	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—PENK—narcolepsy	0.00227	0.00259	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—TRH—narcolepsy	0.00224	0.00256	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—HCRT—narcolepsy	0.00217	0.00247	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—HCRT—narcolepsy	0.00214	0.00245	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00214	0.00244	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00214	0.00244	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—NPS—narcolepsy	0.00211	0.00241	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—TAC1—narcolepsy	0.00211	0.00241	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—HCRT—narcolepsy	0.0021	0.0024	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—PENK—narcolepsy	0.00206	0.00236	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—PENK—narcolepsy	0.00206	0.00236	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—HCRTR2—narcolepsy	0.00204	0.00233	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—HCRTR1—narcolepsy	0.00204	0.00233	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—HCRT—narcolepsy	0.00197	0.00225	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—P2RY11—narcolepsy	0.00197	0.00225	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—HRH3—narcolepsy	0.00197	0.00225	CbGpPWpGaD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00196	0.00224	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00195	0.00222	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—HCRT—narcolepsy	0.00194	0.00222	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—TRH—narcolepsy	0.00193	0.00221	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—PENK—narcolepsy	0.00193	0.00221	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—PENK—narcolepsy	0.00191	0.00218	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—PENK—narcolepsy	0.00187	0.00214	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—HCRTR1—narcolepsy	0.00185	0.00211	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—HCRTR2—narcolepsy	0.00185	0.00211	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—P2RY11—narcolepsy	0.00179	0.00204	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—TRH—narcolepsy	0.00175	0.002	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—PENK—narcolepsy	0.00175	0.002	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—TRH—narcolepsy	0.00175	0.002	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—PENK—narcolepsy	0.00173	0.00198	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—HRH3—narcolepsy	0.00169	0.00193	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—HCRT—narcolepsy	0.00167	0.00191	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00167	0.00191	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HCRTR2—narcolepsy	0.00166	0.0019	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HCRTR1—narcolepsy	0.00166	0.0019	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—TRH—narcolepsy	0.00164	0.00188	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—TAC1—narcolepsy	0.00163	0.00186	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—NPS—narcolepsy	0.00163	0.00186	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—TRH—narcolepsy	0.00162	0.00185	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—P2RY11—narcolepsy	0.00161	0.00184	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—TRH—narcolepsy	0.00159	0.00182	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—HRH3—narcolepsy	0.00154	0.00176	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—HRH3—narcolepsy	0.00154	0.00176	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—HCRT—narcolepsy	0.00152	0.00174	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HCRTR2—narcolepsy	0.00151	0.00173	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HCRTR1—narcolepsy	0.00151	0.00173	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.0015	0.00172	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—HTR2A—narcolepsy	0.00149	0.00171	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—TRH—narcolepsy	0.00149	0.0017	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—PENK—narcolepsy	0.00149	0.0017	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—TRH—narcolepsy	0.00147	0.00168	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—P2RY11—narcolepsy	0.00146	0.00167	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—HRH3—narcolepsy	0.00144	0.00164	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—HRH3—narcolepsy	0.00142	0.00163	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HCRTR2—narcolepsy	0.00142	0.00162	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HCRTR1—narcolepsy	0.00142	0.00162	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—NPS—narcolepsy	0.0014	0.0016	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—TAC1—narcolepsy	0.0014	0.0016	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HCRTR2—narcolepsy	0.0014	0.0016	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HCRTR1—narcolepsy	0.0014	0.0016	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—HRH3—narcolepsy	0.0014	0.00159	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HCRT—narcolepsy	0.00137	0.00156	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—P2RY11—narcolepsy	0.00137	0.00156	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—PENK—narcolepsy	0.00135	0.00155	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—P2RY11—narcolepsy	0.00135	0.00154	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—HRH3—narcolepsy	0.00131	0.00149	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—HRH3—narcolepsy	0.00129	0.00148	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00129	0.00147	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—NPS—narcolepsy	0.00127	0.00146	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—TAC1—narcolepsy	0.00127	0.00146	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—TAC1—narcolepsy	0.00127	0.00146	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—NPS—narcolepsy	0.00127	0.00146	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—HTR2A—narcolepsy	0.00127	0.00145	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—TRH—narcolepsy	0.00127	0.00145	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HCRT—narcolepsy	0.00124	0.00142	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PENK—narcolepsy	0.00122	0.00139	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—TAC1—narcolepsy	0.00119	0.00136	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—NPS—narcolepsy	0.00119	0.00136	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—TAC1—narcolepsy	0.00118	0.00135	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—NPS—narcolepsy	0.00118	0.00135	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HCRT—narcolepsy	0.00116	0.00133	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—NPS—narcolepsy	0.00116	0.00132	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—TAC1—narcolepsy	0.00116	0.00132	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—TRH—narcolepsy	0.00115	0.00132	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HCRT—narcolepsy	0.00115	0.00131	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—HRH3—narcolepsy	0.00111	0.00127	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PENK—narcolepsy	0.00111	0.00126	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HCRTR1—narcolepsy	0.00109	0.00125	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HCRTR2—narcolepsy	0.00109	0.00125	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—NPS—narcolepsy	0.00108	0.00124	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—TAC1—narcolepsy	0.00108	0.00124	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—TAC1—narcolepsy	0.00107	0.00122	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—NPS—narcolepsy	0.00107	0.00122	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—P2RY11—narcolepsy	0.00106	0.00121	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PENK—narcolepsy	0.00104	0.00118	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TRH—narcolepsy	0.00104	0.00118	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PENK—narcolepsy	0.00102	0.00117	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—HRH3—narcolepsy	0.00101	0.00115	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—HTR2A—narcolepsy	0.00098	0.00112	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TRH—narcolepsy	0.000941	0.00107	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000925	0.00106	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—TAC1—narcolepsy	0.000921	0.00105	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—NPS—narcolepsy	0.000921	0.00105	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HRH3—narcolepsy	0.000908	0.00104	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HCRT—narcolepsy	0.000897	0.00103	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TRH—narcolepsy	0.000881	0.00101	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TRH—narcolepsy	0.00087	0.000994	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—HTR2A—narcolepsy	0.000844	0.000964	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—TAC1—narcolepsy	0.000836	0.000955	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—NPS—narcolepsy	0.000836	0.000955	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HRH3—narcolepsy	0.000825	0.000942	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PENK—narcolepsy	0.0008	0.000914	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HRH3—narcolepsy	0.000772	0.000882	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—HTR2A—narcolepsy	0.000766	0.000876	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—HTR2A—narcolepsy	0.000766	0.000876	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HRH3—narcolepsy	0.000763	0.000872	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TAC1—narcolepsy	0.000753	0.00086	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NPS—narcolepsy	0.000753	0.00086	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—HTR2A—narcolepsy	0.000718	0.00082	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.000713	0.000814	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.000713	0.000814	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—HTR2A—narcolepsy	0.000709	0.00081	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—HTR2A—narcolepsy	0.000696	0.000795	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NPS—narcolepsy	0.000683	0.000781	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TAC1—narcolepsy	0.000683	0.000781	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TRH—narcolepsy	0.00068	0.000777	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—HTR2A—narcolepsy	0.000652	0.000744	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—HTR2A—narcolepsy	0.000644	0.000736	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TAC1—narcolepsy	0.00064	0.000731	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NPS—narcolepsy	0.00064	0.000731	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TAC1—narcolepsy	0.000632	0.000722	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NPS—narcolepsy	0.000632	0.000722	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000629	0.000718	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HRH3—narcolepsy	0.000596	0.000681	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—HTR2A—narcolepsy	0.000554	0.000633	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—HTR2A—narcolepsy	0.000503	0.000575	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NPS—narcolepsy	0.000494	0.000564	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TAC1—narcolepsy	0.000494	0.000564	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HTR2A—narcolepsy	0.000453	0.000517	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CHKB—narcolepsy	0.000412	0.000471	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HTR2A—narcolepsy	0.000411	0.00047	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HTR2A—narcolepsy	0.000385	0.00044	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HTR2A—narcolepsy	0.00038	0.000435	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HTR2A—narcolepsy	0.000297	0.00034	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CPT1B—narcolepsy	0.00028	0.00032	CbGpPWpGaD
